(Q52924018)

English

Risk of serious bacterial infection: treatment with anti-TNF versus methotrexate.

scientific article published on 21 August 2007

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

title

Risk of serious bacterial infection: treatment with anti-TNF versus methotrexate. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

0 references

Angela Zink

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

Joachim Listing

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

publication date

21 August 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

published in

Nature Clinical Practice Rheumatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

page(s)

546-547

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

cites work

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNCPRHEUM0594

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNCPRHEUM0594

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNCPRHEUM0594

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1038/NCPRHEUM0594

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

PubMed publication ID

17712325

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17712325

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/17712325

(Q52924018)

Risk of serious bacterial infection: treatment with anti-TNF versus methotrexate.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)